Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.
作者信息
Felip Eudald, Garcia-Vidal Edurne, Cabrero-de Las Heras Sara, Bernat-Peguera Adrià, Cirauqui Beatriz, Bergamino Milana, Quiroga Vanesa, Teruel Iris, Ferrando-Díez Angelica, Pous Anna, Lopez-Paradís Assumpció, Boronat Laia, Romeo Marga, Mesía Ricard, Fernandez Pedro Luis, Clotet Bonaventura, Riveira-Muñoz Eva, Martínez-Cardús Anna, Ballana Ester, Margelí Mireia
机构信息
Institut Català d'Oncologia-Badalona, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Translational Program in Cancer Research (CARE) Program in Health Research Institute Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.
出版信息
Clin Transl Med. 2025 Aug;15(8):e70426. doi: 10.1002/ctm2.70426.
Abstract
摘要
Zotero 插件